Human Immunodeficiency Virus Type 1 (HIV-1) (glycosylated) antibody

Catalog No. ABIN112973

The Goat Polyclonal anti-Human Immunodeficiency Virus Type 1 antibody is suitable to detect Human Immunodeficiency Virus Type 1 in samples from Human Immunodeficiency Virus (HIV). It has been validated for WB, EIA, IF and IHC (fro).

Quick Overview for Human Immunodeficiency Virus Type 1 (HIV-1) (glycosylated) antibody (ABIN112973)

Target: Human Immunodeficiency Virus Type 1 (HIV-1)

Reactivity: Human Immunodeficiency Virus (HIV)

Host: Goat

Clonality: Polyclonal

Conjugate: Un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Product Details

Binding Specificity: glycosylated

Purification: Sodium Sulfate Precipitation and Ion Exchange Chromatography.

Immunogen: Recombinant (P. Pastoris) ectodomain of gp41 (glycosylated)

Application Details

Application Notes: ELISA. Western blot: 1/1000. Immunofluorescence Microscopy. Immunohistochemistry on Frozen Tissues.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4-5 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 with 0.09 % Sodium Azide as preservative without stabilizing proteins.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details

Target: Human Immunodeficiency Virus Type 1 (HIV-1)

Alternative Name: HIV-1

Target Type: Virus

Background: HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1